|
1
|
Claude N, Christakis M and Tsatsakis AM:
Stem cell technologies in toxicology assessments. Toxicology.
270:1–2. 2009.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Tsatsakis A, Docea AO, Calina D, Tsarouhas
K, Zamfira LM, Mitrut R, Sharifi-Rad J, Kovatsi L, Siokas V,
Dardiotis E, et al: A mechanistic and pathophysiological approach
for stroke associated with drugs of abuse. J Clin Med.
8(1295)2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Dardiotis E, Aloizou AM, Markoula S,
Siokas V, Tsarouhas K, Tzanakakis G, Libra M, Kyritsis AP, Brotis
AG, Aschner M, et al: Cancer-associated stroke: Pathophysiology,
detection and management (Review). Int J Oncol. 54:779–796.
2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Devetzi M, Goulielmaki M, Khoury N,
Spandidos DA, Sotiropoulou G, Christodoulou I and Zoumpourlis V:
Genetically modified stem cells in treatment of human diseases:
Tissue kallikrein (KLK1) based targeted therapy (Review). Int J Mol
Med. 41:1177–1186. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Yu X, Wang X, Zeng S and Tuo X: Protective
effects of primary neural stem cell treatment in ischemic stroke
models. Exp Ther Med. 16:2219–2228. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bunevicius A, Yuan H and Lin W: The
potential roles of 18F-FDG-PET in management of acute stroke
patients. Biomed Res Int. 2013(634598)2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Dundar A, Bold MS, Agac B, Kendi AT and
Friedman SN: Stroke detection with 3 different PET tracers. Radiol
Case Rep. 14:1447–1451. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Aiello M, Cavaliere C, Marchitelli R,
d'Albore A, De Vita E and Salvatore M: Hybrid PET/MRI methodology.
Int Rev Neurobiol. 141:97–128. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Grønberg NV, Johansen FF, Kristiansen U
and Hasseldam H: Leukocyte infiltration in experimental stroke. J
Neuroinflammation. 10(115)2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kernagis DN and Laskowitz DT: Evolving
role of biomarkers in acute cerebrovascular disease. Ann Neurol.
71:289–303. 2012.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Quillinan N, Herson PS and Traystman RJ:
Neuropathophysiology of Brain Injury. Anesthesiol Clin. 34:453–464.
2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Pradeep H, Diya JB, Shashikumar S and
Rajanikant GK: Oxidative stress - assassin behind the ischemic
stroke. Folia Neuropathol. 50:219–230. 2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Dluzniewska J, Sarnowska A, Beresewicz M,
Johnson I, Srai SK, Ramesh B, Goldspink G, Górecki DC and Zabłocka
B: A strong neuroprotective effect of the autonomous C-terminal
peptide of IGF-1 Ec (MGF) in brain ischemia. FASEB J. 19:1896–1898.
2005.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Sohrabji F: Estrogen-IGF-1 interactions in
neuroprotection: Ischemic stroke as a case study. Front
Neuroendocrinol. 36:1–14. 2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Smith PF: Neuroprotection against
hypoxia-ischemia by insulin-like growth factor-I (IGF-I). IDrugs.
6:1173–1177. 2003.PubMed/NCBI
|
|
16
|
Zeng W, Ju R and Mao M: Therapeutic
potential of hepatocyte growth factor against cerebral ischemia
(Review). Exp Ther Med. 9:283–288. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ji Q, Ji Y, Peng J, Zhou X, Chen X, Zhao
H, Xu T, Chen L and Xu Y: Increased brain-specific miR-9 and
miR-124 in the serum exosomes of acute ischemic stroke patients.
PLoS One. 11(e0163645)2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Jadavji NM, Emmerson JT, MacFarlane AJ,
Willmore WG and Smith PD: B-vitamin and choline supplementation
increases neuroplasticity and recovery after stroke. Neurobiol Dis.
103:89–100. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Jadavji NM, Emmerson JT, Shanmugalingam U,
MacFarlane AJ, Willmore WG and Smith PD: A genetic deficiency in
folic acid metabolism impairs recovery after ischemic stroke. Exp
Neurol. 309:14–22. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kim JM, Stewart R, Park MS, Kang HJ, Kim
SW, Shin IS, Kim HR, Shin MG, Cho KH and Yoon JS: Associations of
BDNF genotype and promoter methylation with acute and long-term
stroke outcomes in an East Asian cohort. PLoS One.
7(e51280)2012.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wei LK, Au A, Menon S, Gan SH and
Griffiths LR: Clinical relevance of MTHFR, eNOS, ACE, and ApoE gene
polymorphisms and serum vitamin profile among Malay patients with
ischemic stroke. J Stroke Cerebrovasc Dis. 24:2017–2025.
2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Webb RL, Kaiser EE, Scoville SL, Thompson
TA, Fatima S, Pandya C, Sriram K, Swetenburg RL, Vaibhav K, Arbab
AS, et al: Human neural stem cell extracellular vesicles improve
tissue and functional recovery in the murine thromboembolic stroke
model. Transl Stroke Res. 9:530–539. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Stancioiu F and Makk R: Post-stroke
recovery of motor function with a new combination of medicines - A
pilot study. EJMO. 3:167–181. 2019.
|
|
24
|
Chun SY, Lim JO, Lee EH, Han MH, Ha YS,
Lee JN, Kim BS, Park MJ, Yeo M, Jung B and Kwon TG: Preparation and
characterization of human adipose tissue-derived extracellular
matrix, growth factors, and stem cells: a concise review. Tissue
Eng Regen Med. 16:385–393. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Bogdanova A, Berzins U, Nikulshin S,
Skrastina D, Ezerta A, Legzdina D and Kozlovska T: Characterization
of human adipose-derived stem cells cultured in autologous serum
after subsequent passaging and long term cryopreservation. J Stem
Cells. 9:135–148. 2014.PubMed/NCBI
|
|
26
|
Kozlowska U, Krawczenko A, Futoma K, Jurek
T, Rorat M, Patrzalek D and Klimczak A: Similarities and
differences between mesenchymal stem/progenitor cells derived from
various human tissues. World J Stem Cells. 11:347–374.
2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Mazini L, Rochette L, Amine M and Malka G:
Regenerative capacity of adipose derived stem cells (ADSCs),
comparison with mesenchymal stem cells (MSCs). Int J Mol Sci.
20(E2523)2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Barilani M, Banfi F, Sironi S, Ragni E,
Guillaumin S, Polveraccio F, Rosso L, Moro M, Astori G, Pozzobon M
and Lazzari L: Low-affinity nerve growth factor receptor (CD271)
heterogeneous expression in adult and fetal mesenchymal stromal
cells. Sci Rep. 8(9321)2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Heo JS, Choi Y, Kim HS and Kim HO:
Comparison of molecular profiles of human mesenchymal stem cells
derived from bone marrow, umbilical cord blood, placenta and
adipose tissue. Int J Mol Med. 37:115–125. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Li CY, Wu XY, Tong JB, Yang XX, Zhao JL,
Zheng QF, Zhao GB and Ma ZJ: Comparative analysis of human
mesenchymal stem cells from bone marrow and adipose tissue under
xeno-free conditions for cell therapy. Stem Cell Res Ther.
6(55)2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Nakao N, Nakayama T, Yahata T, Muguruma Y,
Saito S, Miyata Y, Yamamoto K and Naoe T: Adipose tissue-derived
mesenchymal stem cells facilitate hematopoiesis in vitro and in
vivo: Advantages over bone marrow-derived mesenchymal stem cells.
Am J Pathol. 177:547–554. 2010.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Urrutia DN, Caviedes P, Mardones R,
Minguell JJ, Vega-Letter AM and Jofre CM: Comparative study of the
neural differentiation capacity of mesenchymal stromal cells from
different tissue sources: An approach for their use in neural
regeneration therapies. PLoS One. 14(e0213032)2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
O'Connor KC: Molecular profiles of
cell-to-cell variation in the regenerative potential of mesenchymal
stromal cells. Stem Cells Int. 2019(5924878)2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Ikegame Y, Yamashita K, Hayashi S, Mizuno
H, Tawada M, You F, Yamada K, Tanaka Y, Egashira Y, Nakashima S, et
al: Comparison of mesenchymal stem cells from adipose tissue and
bone marrow for ischemic stroke therapy. Cytotherapy. 13:675–685.
2011.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Quirici N, Scavullo C, de Girolamo L, Lopa
S, Arrigoni E, Deliliers GL and Brini AT: Anti-L-NGFR and -CD34
monoclonal antibodies identify multipotent mesenchymal stem cells
in human adipose tissue. Stem Cells Dev. 19:915–925.
2010.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Safford KM, Hicok KC, Safford SD,
Halvorsen YD, Wilkison WO, Gimble JM and Rice HE: Neurogenic
differentiation of murine and human adipose-derived stromal cells.
Biochem Biophys Res Commun. 294:371–379. 2002.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Chung JY, Kim W, Im W, Yoo DY, Choi JH,
Hwang IK, Won MH, Chang IB, Cho BM, Hwang HS, et al:
Neuroprotective effects of adipose-derived stem cells against
ischemic neuronal damage in the rabbit spinal cord. J Neurol Sci.
317:40–46. 2012.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Jeon D, Chu K, Lee ST, Jung KH, Ban JJ,
Park DK, Yoon HJ, Jung S, Yang H, Kim BS, et al: Neuroprotective
effect of a cell-free extract derived from human adipose stem cells
in experimental stroke models. Neurobiol Dis. 54:414–420.
2013.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Doeppner TR and Hermann DM: Mesenchymal
stem cells in the treatment of ischemic stroke: progress and
possibilities. Stem Cells Cloning. 3:157–163. 2010.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Kuçi S, Kuçi Z, Kreyenberg H, Deak E,
Pütsch K, Huenecke S, Amara C, Koller S, Rettinger E, Grez M, et
al: CD271 antigen defines a subset of multipotent stromal cells
with immunosuppressive and lymphohematopoietic
engraftment-promoting properties. Haematologica. 95:651–659.
2010.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Álvarez-Viejo M, Menéndez-Menéndez Y and
Otero-Hernández J: CD271 as a marker to identify mesenchymal stem
cells from diverse sources before culture. World J Stem Cells.
7:470–476. 2015.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Meyerrose TE, De Ugarte DA, Hofling AA,
Herrbrich PE, Cordonnier TD, Shultz LD, Eagon JC, Wirthlin L, Sands
MS, Hedrick MA, et al: In vivo distribution of human
adipose-derived mesenchymal stem cells in novel xenotransplantation
models. Stem Cells. 25:220–227. 2007.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Jones E and McGonagle D: Human bone marrow
mesenchymal stem cells in vivo. Rheumatology (Oxford). 47:126–131.
2008.PubMed/NCBI View Article : Google Scholar
|
|
44
|
George S, Hamblin MR and Abrahamse H:
Differentiation of mesenchymal stem cells to neuroglia: in the
context of cell signalling. Stem Cell Rev Rep. 15:814–826.
2019.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Hermann A, List C, Habisch HJ, Vukicevic
V, Ehrhart-Bornstein M, Brenner R, Bernstein P, Fickert S and
Storch A: Age-dependent neuroectodermal differentiation capacity of
human mesenchymal stromal cells: Limitations for autologous cell
replacement strategies. Cytotherapy. 12:17–30. 2010.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Surugiu R, Olaru A, Hermann DM, Glavan D,
Catalin B and Popa-Wagner A: Recent advances in mono- and combined
stem cell therapies of stroke in animal models and humans. Int J
Mol Sci. 20(6029)2019.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Gutiérrez-Fernández M, Rodríguez-Frutos B,
Otero-Ortega L, Ramos-Cejudo J, Fuentes B and Díez-Tejedor E:
Adipose tissue derived stem cells in stroke treatment, from bench
to bedside. Discov Med. 16:37–43. 2013.PubMed/NCBI
|
|
48
|
U.S. National Library of Medicine:
Reparative therapy in acute ischemic stroke with allogenic
mesenchymal stem cells from adipose tissue, safety assessment, a
randomised, double blind placebo controlled single center pilot
clinical trial (AMASCIS-01). http://ClinicalTrials.govsimpleClinicalTrials.gov
Identifier: NCT01678534. https://clinicaltrials.gov/ct2/show/NCT01678534?term=stem+cells&cond=stroke&draw=3&rank=16.
Accessed January 10, 2020.
|
|
49
|
Bang OY, Lee JS, Lee PH and Lee G:
Autologous mesenchymal stem cell transplantation in stroke
patients. Ann Neurol. 57:874–882. 2005.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Lee JS, Hong JM, Moon GJ, Lee PH, Ahn YH
and Bang OY: STARTING collaborators. A long-term follow-up study of
intravenous autologous mesenchymal stem cell transplantation in
patients with ischemic stroke. Stem Cells. 28:1099–1106.
2010.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Pan K, Deng L, Chen P, Peng Q, Pan J, Wu Y
and Yang Y: Safety and feasibility of repeated intrathecal
allogeneic bone marrow-derived mesenchymal stromal cells in
patients with neurological diseases. Stem Cells Int.
2019(8421281)2019.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Boncoraglio GB, Ranieri M, Bersano A,
Parati EA and Del Giovane C: Stem cell transplantation for ischemic
stroke. Cochrane Database Syst Rev. 5(CD007231)2019.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Steinberg GK, Kondziolka D, Wechsler LR,
Lunsford LD, Kim AS, Johnson JN, Bates D, Poggio G, Case C,
McGrogan M, et al: Two-year safety and clinical outcomes in chronic
ischemic stroke patients after implantation of modified bone
marrow-derived mesenchymal stem cells (SB623): A phase 1/2a study.
J Neurosurg. 131:1462–1472. 2019.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Hill WD, Hess DC, Martin-Studdard A,
Carothers JJ, Zheng J, Hale D, Maeda M, Fagan SC, Carroll JE and
Conway SJ: SDF-1 (CXCL12) is upregulated in the ischemic penumbra
following stroke: Association with bone marrow cell homing to
injury. J Neuropathol Exp Neurol. 63:84–96. 2004.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Barbosa da Fonseca LM, Gutfilen B, Rosado
de Castro PH, Battistella V, Goldenberg RC, Kasai-Brunswick T,
Chagas CL, Wajnberg E, Maiolino A, Salles Xavier S, et al:
Migration and homing of bone-marrow mononuclear cells in chronic
ischemic stroke after intra-arterial injection. Exp Neurol.
221:122–128. 2010.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Samoilova EM, Kalsin VA, Kushnir NM,
Chistyakov DA, Troitskiy AV and Baklaushev VP: Adult neural stem
cells: basic research and production strategies for
neurorestorative therapy. Stem Cells Int.
2018(4835491)2018.PubMed/NCBI View Article : Google Scholar
|
